[{"address1": "2450 Holcombe Blvd.", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "(713) 913-5608", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "As of November 13, 2025, Salarius Pharmaceuticals, Inc. was acquired by Decoy Therapeutics Inc., in a reverse merger transaction. Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is based in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.21, "open": 1.15, "dayLow": 1.1308, "dayHigh": 1.29, "regularMarketPreviousClose": 1.21, "regularMarketOpen": 1.15, "regularMarketDayLow": 1.1308, "regularMarketDayHigh": 1.29, "payoutRatio": 0.0, "beta": 0.333, "forwardPE": -0.1308615, "volume": 2107120, "regularMarketVolume": 2107120, "averageVolume": 1692198, "averageVolume10days": 9450770, "averageDailyVolume10Day": 9450770, "bid": 0.9216, "ask": 1.47, "bidSize": 2, "askSize": 2, "marketCap": 1272126, "fiftyTwoWeekLow": 0.91, "fiftyTwoWeekHigh": 108.0, "allTimeHigh": 1861500.0, "allTimeLow": 0.91, "fiftyDayAverage": 3.834, "twoHundredDayAverage": 10.62705, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -753770, "profitMargins": 0.0, "floatShares": 33957, "sharesOutstanding": 1051782, "sharesShort": 360165, "sharesShortPriorMonth": 117000, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.3424, "heldPercentInsiders": 0.00017000001, "heldPercentInstitutions": 0.00171, "shortRatio": 1.48, "shortPercentOfFloat": 0.3427, "impliedSharesOutstanding": 1060105, "bookValue": -0.39, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -5103412, "trailingEps": -23.7, "forwardEps": -9.17, "lastSplitFactor": "1:15", "lastSplitDate": 1755475200, "enterpriseToEbitda": 0.133, "52WeekChange": -0.942029, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 1.2, "recommendationKey": "none", "totalCash": 794886, "totalCashPerShare": 23.393, "ebitda": -5675021, "totalDebt": 0, "quickRatio": 0.358, "currentRatio": 0.612, "returnOnAssets": -1.43519, "returnOnEquity": -6.60367, "freeCashflow": -2657078, "operatingCashflow": -4143201, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.826446, "regularMarketPrice": 1.2, "corporateActions": [], "postMarketTime": 1763168348, "regularMarketTime": 1763154000, "exchange": "NCM", "messageBoardId": "finmb_1681482131", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Salarius Pharmaceuticals, Inc.", "longName": "Salarius Pharmaceuticals, Inc.", "postMarketChangePercent": -3.358334, "postMarketPrice": 1.1597, "postMarketChange": -0.04030001, "regularMarketChange": -0.00999999, "regularMarketDayRange": "1.1308 - 1.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1692198, "fiftyTwoWeekLowChange": 0.29000002, "fiftyTwoWeekLowChangePercent": 0.31868133, "fiftyTwoWeekRange": "0.91 - 108.0", "fiftyTwoWeekHighChange": -106.8, "fiftyTwoWeekHighChangePercent": -0.9888889, "fiftyTwoWeekChangePercent": -94.202896, "dividendDate": 1563753600, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -23.7, "epsForward": -9.17, "fiftyDayAverageChange": -2.634, "fiftyDayAverageChangePercent": -0.68701094, "twoHundredDayAverageChange": -9.427051, "twoHundredDayAverageChangePercent": -0.8870806, "priceToBook": -3.0769234, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]